Amneal Pharmaceuticals of New York, LLC recalls Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal
Recalled August 31, 2022 · FDA recall D-1362-2022 · Amneal Pharmaceuticals of New York
Hazard
Failed dissolution specifications. · FDA Class II
Units
4,309 bottles
Sold at
USA nationwide
Description
Failed dissolution specifications.
Product
Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10
Manufacturer(s)
Amneal Pharmaceuticals of New York, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →